• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 3. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 4. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

Introduction to 1,2-Ethanediamine, N-[(2-chloro-4-fluorophenyl)methyl]- (CAS No: 622373-88-0)

1,2-Ethanediamine, N-[(2-chloro-4-fluorophenyl)methyl]-, identified by its Chemical Abstracts Service (CAS) number 622373-88-0, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of diamines, characterized by the presence of two amino groups (-NH?) attached to a methylene bridge (-CH?-). The structural modification introduced by the N-[(2-chloro-4-fluorophenyl)methyl] moiety imparts unique chemical properties and functional capabilities, making it a valuable intermediate in the synthesis of various bioactive molecules.

The 1,2-Ethanediamine backbone provides a versatile framework for further chemical modifications, enabling the development of complex molecular architectures. This feature is particularly useful in drug design, where precise control over molecular structure is essential for optimizing pharmacological activity. The presence of both amino groups allows for the formation of multiple hydrogen bonds, which can enhance binding affinity to biological targets. Additionally, the electron-withdrawing nature of the chloro and fluoro substituents on the aromatic ring influences the electronic properties of the molecule, potentially affecting its reactivity and interactions with biological systems.

In recent years, there has been growing interest in exploring the therapeutic potential of compounds derived from diamines due to their ability to modulate various biological pathways. Research has demonstrated that diamines can serve as key structural motifs in the development of antimicrobial agents, anticancer drugs, and neuroprotective compounds. The specific substitution pattern in 1,2-Ethanediamine, N-[(2-chloro-4-fluorophenyl)methyl]- makes it a promising candidate for further investigation in these areas.

One of the most compelling aspects of this compound is its potential application in the synthesis of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways and are frequently targeted in anticancer therapies. The ability of 1,2-Ethanediamine, N-[(2-chloro-4-fluorophenyl)methyl] to act as a scaffold for designing kinase inhibitors lies in its capacity to form stable interactions with the active site of these enzymes. The amino groups can engage in hydrogen bonding with key residues, while the aromatic ring can stack with hydrophobic pockets within the kinase active site. This dual interaction mode enhances binding affinity and selectivity.

Recent studies have highlighted the importance of fluorinated aromatic rings in enhancing drug bioavailability and metabolic stability. The fluoro substituent in 1,2-Ethanediamine, N-[(2-chloro-4-fluorophenyl)methyl] contributes to these properties by increasing lipophilicity and reducing susceptibility to enzymatic degradation. Additionally, the chloro group can serve as a handle for further derivatization, allowing chemists to fine-tune the pharmacokinetic profile of potential drug candidates.

The synthesis of 1,2-Ethanediamine, N-[(2-chloro-4-fluorophenyl)methyl] involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include nucleophilic substitution reactions followed by condensation steps to introduce the diamine functionality. Advanced techniques such as palladium-catalyzed cross-coupling reactions have also been employed to construct the desired aromatic ring system efficiently.

In addition to its pharmaceutical applications, this compound has shown promise in materials science. The unique structural features of 1,2-Ethanediamine, N-[(2-chloro-4-fluorophenyl)methyl] make it suitable for designing functional materials with tailored properties. For instance, its ability to form coordination complexes with metal ions suggests potential use in catalysis or as a ligand for metal-based drugs.

The safety profile of 1,2-Ethanediamine, N-[(2-chloro-4-fluorophenyl)methyl] is another critical consideration in its application. While preliminary studies suggest that it exhibits moderate solubility in organic solvents and water, further toxicological assessments are necessary to evaluate its potential effects on human health and environmental systems. These studies will help determine appropriate handling procedures and regulatory compliance requirements.

Future research directions may focus on exploring derivatives of this compound that exhibit enhanced biological activity or improved pharmacokinetic properties. Computational modeling techniques can play a significant role in predicting molecular interactions and guiding synthetic efforts towards more effective drug candidates. Additionally, green chemistry principles should be integrated into synthetic protocols to minimize environmental impact and improve sustainability.

In conclusion,1,2-Ethanediamine, N-[(2-chloro-4-fluorophenyl)methyl]- (CAS No: 622373-88-0) represents a structurally intriguing compound with diverse applications in pharmaceuticals and materials science. Its unique combination of functional groups and electronic properties makes it a valuable building block for developing innovative therapeutics and functional materials. Continued research efforts will further elucidate its potential benefits and ensure its safe and effective utilization across various scientific disciplines.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)